Blood-borne compounds (such as tissue plasminogen activator) that work to disintegrate (break up or lyse) blood clots.
These are compounds with the property of breaking up blood clots in the circulatory system.
Any drug that degrades blood clots. Examples include streptokinase, tenecteplase, tissue plasminogen activator, and urokinase. Such drugs are used to treat the abnormal blood clotting that occurs in heart attacks, some strokes, and pulmonary emboli.